Literature DB >> 8152371

Bacillus anthracis pXO1 virulence plasmid encodes a type 1 DNA topoisomerase.

A Fouet1, J C Sirard, M Mock.   

Abstract

The virulence plasmid pXO1 is responsible for toxin production in Bacillus anthracis. A DNA fragment from pXO1 was isolated and was shown, by sequence analysis, to contain part of a type 1 DNA topoisomerase gene. Attempts to clone the entire wild-type gene, designated topX, in Escherichia coli, were unsuccessful. In order to obtain the complete gene, it was first insertionally inactivated and then cloned in the mutated form. The deduced amino acid sequence of Topo X1 shows similarities to that of the two E. coli type 1 DNA topoisomerases. The N-terminal two-thirds of the putative B. anthracis protein exhibits strongest sequence similarity to topoisomerase III, whereas the C-terminal portion contains cysteine residues that could form three zinc-binding domains, as they do in topoisomerase I. The suggested active-site tyrosine is conserved in all three proteins. The regulation of expression from the topX promoter is modified by addition of a gyrase inhibiting antibiotic. The Topo X1 protein is likely to be involved in the stability of pXO1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152371     DOI: 10.1111/j.1365-2958.1994.tb00328.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  10 in total

Review 1.  Antibiotic resistance: a current perspective.

Authors:  K F Barker
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103.

Authors:  S Takai; S A Hines; T Sekizaki; V M Nicholson; D A Alperin; M Osaki; D Takamatsu; M Nakamura; K Suzuki; N Ogino; T Kakuda; H Dan; J F Prescott
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Determination of the recognition sequence of Mycobacterium smegmatis topoisomerase I on mycobacterial genomic sequences.

Authors:  D Sikder; V Nagaraja
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

4.  Bacillus anthracis pXO1 plasmid sequence conservation among closely related bacterial species.

Authors:  James Pannucci; Richard T Okinaka; Robert Sabin; Cheryl R Kuske
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

5.  The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature.

Authors:  J C Sirard; M Mock; A Fouet
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

6.  Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes.

Authors:  R T Okinaka; K Cloud; O Hampton; A R Hoffmaster; K K Hill; P Keim; T M Koehler; G Lamke; S Kumano; J Mahillon; D Manter; Y Martinez; D Ricke; R Svensson; P J Jackson
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

7.  The tubulin-like RepX protein encoded by the pXO1 plasmid forms polymers in vivo in Bacillus anthracis.

Authors:  Parvez Akhtar; Syam P Anand; Simon C Watkins; Saleem A Khan
Journal:  J Bacteriol       Date:  2009-02-20       Impact factor: 3.490

Review 8.  Bacillus anthracis physiology and genetics.

Authors:  Theresa M Koehler
Journal:  Mol Aspects Med       Date:  2009-08-03

9.  The genome sequence of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1.

Authors:  David A Rasko; Jacques Ravel; Ole Andreas Økstad; Erlendur Helgason; Regina Z Cer; Lingxia Jiang; Kelly A Shores; Derrick E Fouts; Nicolas J Tourasse; Samuel V Angiuoli; James Kolonay; William C Nelson; Anne-Brit Kolstø; Claire M Fraser; Timothy D Read
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

10.  Bacillus cereus DNA topoisomerase I and IIIalpha: purification, characterization and complementation of Escherichia coli TopoIII activity.

Authors:  Zhiyu Li; Hiroshi Hiasa; Russell DiGate
Journal:  Nucleic Acids Res       Date:  2005-09-28       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.